Westfield reports 0 shares in Bicycle Therapeutics (NASDAQ: BCYC)

NodeGuardian · 2026-03-09T15:36:50+00:00

Westfield Capital Management filed an Amendment No. 2 to Schedule 13G, reporting it owns 0 shares of Bicycle Therapeutics as of December 31, 2025, with no voting power. The amendment was signed by Brandi McMahon on March 3, 2026.

NodeGuardian

2026-03-09 15:36:50

Abstract generation in progress

Westfield Capital Management Company, L.P. filed an Amendment No. 2 to a Schedule 13G, reporting that it beneficially owned 0 shares of Bicycle Therapeutics plc (NASDAQ: BCYC) common stock as of December 31, 2025. The filing indicates no voting or dispositive power held by Westfield for BCYC shares. The amendment was signed by Brandi McMahon, Vice President, Deputy Chief Compliance Officer, and dated March 3, 2026.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.